Gastrointestinal stromal tumors: A clinicopathological and immunohistochemical study of 121 cases

Indian Journal of Gastroenterology

Volumn 29, Issue 6, 2010, Pages 231-236

  Vij, Mukul ^a   Agrawal, Vinita ^a   Kumar, Ashok ^a   Pandey, Rakesh ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

CD117; Gastrointestinal stromal tumors; Gastrointestinal tract; Immunophenotyping; Stomach; Tumor

Indexed keywords

CD34 ANTIGEN; DESMIN; KI 67 ANTIGEN; PROTEIN S 100; SMOOTH MUSCLE ACTIN; STEM CELL FACTOR RECEPTOR;

ADOLESCENT; ADULT; AGED; ANIMAL TISSUE; ARTICLE; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MITOSIS INDEX; NONHUMAN; PROTEIN EXPRESSION; TUMOR LOCALIZATION; TUMOR VOLUME;

ACTINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD34; DESMIN; GASTROINTESTINAL STROMAL TUMORS; HUMANS; KI-67 ANTIGEN; MIDDLE AGED; MITOTIC INDEX; NECROSIS; NEOPLASM INVASIVENESS; PROTO-ONCOGENE PROTEINS C-KIT; S100 PROTEINS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 79955465022     PISSN: 02548860     EISSN: 02548860     Source Type: Journal    
DOI: 10.1007/s12664-010-0079-z     Document Type: Article

References (30)

1. Mazur MT, Clark HB. Gastric stromal tumors. Reappraisal of histogenesis. Am J Surg Pathol. 1983; 7: 507-19.
2. Miettinen M, Virolainen M, Sarlomo-Rikala M. Gastrointestinal stromal tumors-value of CD34 antigen in their identification and separation from true leiomyomas and schwannomas. Am J Surg Pathol. 1995; 19: 207-16.
3. Hirota S, Isozaki K, Moriyama Y, et al. Gain of function mutations of c-kit in human gastrointestinal stromal tumors. Science. 1998; 279: 577-80.
4. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, et al. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD34. Mod Pathol. 1998; 11: 728-34.
5. Lamba M, Mukherjee G, Saini K, et al. Clinico-pathologic pattern of gastrointestinal stromal tumours (GIST) in southern India: A single-institution experience (abstract). J Clin Oncol. 2007; 25(18S): 20531.
6. Nada R, Vaiphei K, Singh R, et al. Gastrointestinal stromal tumours the assessment of malignant potential. Indian J Pathol Microbiol. 2001; 44: 393-7.
7. Miettinen M, Lasota J. Gastrointestinal stromal tumors: pathology and prognosis at different sites. Semin Diagn Pathol. 2006; 23: 70-83.
8. Agaimy A, Wunsch PH. Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra-gastrointestinal stromal tumours. Langenbecks Arch Surg. 2006; 39: 322-9.
9. Reith JD, Goldblum GR, Lyles RH, et al. Extragastrointestinal (soft tissue) stromal tumors: an analysis of 48 cases with emphasis on histologic predictors of outcome. Mod Pathol. 2000; 13: 577-85.
10. Miettinen M, Monihan JM, Sarlomo-Rikala M, et al. Primary in the omentum and mesentery: Clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol. 1999; 23: 1109-18.
11. Steigen SE, Eide TJ. Trends in incidence and survival of mesenchymal neoplasm of the digestive tract within a defined population of Northern Norway. APMIS. 2006; 114: 192-200.
12. Ahmed I, Welch NT, Parsons SL. Gastrointestinal stromal tumors (GIST)-17 years experience from Mid Trent Region (United Kingdom). Eur J Surg Oncol. 2008; 34: 445-9.
13. Tran T, Davila JA, El-Serag HB. The epidemiology of malignant gastrointestinal stromal tumors: An analysis of 1, 458 cases from 1992 to 2000. Am J Gastroenterol. 2005; 100: 162-8.
14. Dematteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: Recurrence patterns and prognostic factors for survival. Ann Surg. 2000; 231: 51-8.
15. Bümming P, Ahlman H, Andersson J, et al. Population-based study of the diagnosis and treatment of gastrointestinal stromal tumours. Br J Surg. 2006; 93: 836-43.
16. Kim KM, Kang DW, Moon WS, et al. Gastrointestinal stromal tumors in Koreans: its incidence and the clinical, pathologic and immunohistochemical findings. J Korean Med Sci. 2005; 20: 977-84.
17. Nilsson B, Bumming P, Meis-Kindblom JM, et al. Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era-a population-based study in western Sweden. Cancer. 2005; 103: 821-9.
18. Rutkowski P, Nowecki ZI, Michej W, et al. Risk criteria and prognostic factors for predicting recurrences after resection of primary gastrointestinal stromal tumor. Ann Surg Oncol. 2007; 14: 2018-27.
19. Brainard JA, Goldblum JR. Stromal tumors of the jejunum and ileum: a clinicopathologic study of 39 cases. Am J Surg Pathol. 1997; 21: 407-16.
20. Tworek JA, Appelman HD, Singleton TP, et al. Stromal tumors of the jejunum and ileum. Mod Pathol. 1997; 10: 200-9.
21. Miettinen M, Sarlomo-Rikala M, Sobin LH, et al. Gastrointestinal stromal tumors and leiomyosarcomas in the colon: a clinicopathologic, immunohistochemical, and molecular genetic study of 44 cases. Am J Surg Pathol. 2000; 24: 1339-52.
22. Miettinen M, Shekitka KM, Sobin LH. Schwannomas in the colon and rectum: a clinicopathologic and immunohistochemical study of 20 cases. Am J Surg Pathol. 2001; 25: 846-55.
23. Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum Pathol. 2002; 33: 669-76.
24. Orosz Z, Tornóczky T, Sápi Z. Gastrointestinal stromal tumors: a clinicopathologic and immunohistochemicalstudy of 136 cases. Pathol Oncol Res. 2005; 11: 11-21.
25. Alvarado-Cabrero I, Vázquez G, Sierra Santiesteban FI, et al. Clinicopathologic study of 275 cases of gastrointestinal stromal tumors: The experience at 3 large medical centers in Mexico. Ann Diagn Pathol. 2007; 11: 39-45.
26. Miettinen M, Sobin LH, Lasota J. Gastrointestinal stromal tumors of the stomach: a clinicopathologic, immunohistochemical, and molecular genetic study of 1765 cases with long-term follow-up. Am J Surg Pathol. 2005; 29: 52-68.
27. Trupiano JK, Stewart RE, Misick C, et al. Gastric stromal tumors: a clinicopathologic study of 77 cases with correlation of features with nonaggressive and aggressive clinical behaviors. Am J Surg Pathol. 2002; 26: 705-14.
28. Miettinen M, Makhlouf H, Sobin LH, et al. Gastrointestinal stromal tumors of the jejunum and ileum: a clinicopathologic, immunohistochemical, and molecular genetic study of 906 cases before imatinib with long-term follow-up. Am J Surg Pathol. 2006; 30: 477-89.
29. Iesalnieks I, Rümmele P, Dietmaier W, et al. Factors associated with disease progression in patients with gastrointestinal stromal tumors in the pre-imatinib era. Am J Clin Pathol. 2005; 124: 740-48.
30. Medeiros F, Corless CL, Duensing A, et al. KIT-negative gastrointestinal stromal tumors: proof of concept and therapeutic implications. Am J Surg Pathol. 2004; 28: 889-94.